Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Noble Romans (NROM) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Noble Romans (NROM) over the last 15 years, with Q2 2025 value amounting to $222.2 million.

  • Noble Romans' Shares Outstanding (Weighted Average) rose 90027.18% to $222.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $222.2 million, marking a year-over-year increase of 90027.18%. This contributed to the annual value of $22.2 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q2 2025, Noble Romans' Shares Outstanding (Weighted Average) is $222.2 million, which was up 90027.18% from $22.2 million recorded in Q1 2025.
  • In the past 5 years, Noble Romans' Shares Outstanding (Weighted Average) registered a high of $222.2 million during Q2 2025, and its lowest value of $22.2 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $33.3 million, with a median of $22.2 million in 2021.
  • In the last 5 years, Noble Romans' Shares Outstanding (Weighted Average) changed by 0.0% in 2021 and then surged by 90027.18% in 2025.
  • Over the past 5 years, Noble Romans' Shares Outstanding (Weighted Average) (Quarter) stood at $22.2 million in 2021, then changed by 0.0% to $22.2 million in 2022, then changed by 0.0% to $22.2 million in 2023, then changed by 0.0% to $22.2 million in 2024, then soared by 900.27% to $222.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $222.2 million for Q2 2025, versus $22.2 million for Q1 2025 and $22.2 million for Q4 2024.